Update on terbinafine with a focus on dermatophytoses
Jason G Newland1,3, Susan M Abdel-Rahman2,3Divisions of Infectious Diseases1 and Clinical Pharmacology and Medical Toxicology2, Children’s Mercy Hospitals and Clinics, Kansas City, MO, USA; 3Department of Pediatrics, University of Missouri-Kansas City, School of Medicine, Kansas City, MO,...
Saved in:
Main Authors: | Jason G Newland (Author), Susan M Abdel-Rahman (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2009-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pathogenesis of dermatophytoses
by: Ram Tainwala, et al.
Published: (2011) -
Comparative assessment of the efficacy and safety of sertaconazole (2%) cream versus terbinafine cream (1%) versus luliconazole (1%) cream in patients with dermatophytoses: A pilot study
by: H R Jerajani, et al.
Published: (2013) -
Atopy as a risk factor for dermatophytoses
by: Hafidh R. Rand, et al.
Published: (2005) -
Managing dermatophytoses in pregnancy, lactation, and children
by: Smitha S Prabhu, et al.
Published: (2017) -
Immunosuppressive Serum Factors in Patients with Dermatophytoses
by: Hafidh R. Rand, et al.
Published: (2005)